Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
iRadimed Corporation logo

iRadimed Corporation

Sector: Healthcare   

Industry: Medical Devices

42.39
 
USD
  
0.56
  
(1.34%)
Optionable: No  Market Cap: 566 M  90-day average vol: 50,087

Previous close: 41.83  Open: 41.7  Bid: 42.24  Ask: 67.84
52 week range    
36.12   
   51.04
Peers   
MLSS / 
NUVA / 
COO / 
Last updated: Monday 26th February 2024
43
MarketXLS Rank
35
Value
30
Technical
65
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

IRMD Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-38499.0-36006.0-18017.0-82399.0-89333.089963.092945.0101735.0-101122.0
Basic EPS from continuing operations0.850.110.76
Basic EPS total0.230.680.670.050.590.850.110.761.02
Basic weighted shares outstanding9 M11 M11 M11 M11 M11 M12 M12 M13 M
Cost of sales-3 M-6 M-6 M-6 M-7 M9 M8 M10 M-12 M
Depreciation-110557.0-187936.0-230282.0-362872.0-470395.0501218.0510652.0532275.0
Depreciation unreconciled-569551.0
DepreciationAndAmortization-110557.0-187936.0-230282.0-362872.0-470395.0501218.0510652.0532275.0-569551.0
Diluted EPS total0.20.60.60.040.520.780.110.741.02
Diluted normalized net income/share0.780.110.74
Diluted weighted shares outstanding10 M13 M12 M12 M12 M12 M12 M13 M13 M
GainOnSaleOfSecurity34693.089337.063045.0-6761.0-29308.010764.017272.018593.08025.0
GeneralAndAdministrativeExpense5 M8 M9 M9 M9 M10 M12 M10 M11 M
Gross operating profit12 M26 M26 M18 M23 M30 M24 M32 M41 M
ImpairmentOfCapitalAssets-55433.0
Income before tax3 M12 M11 M1 M6 M9 M-616878.010 M16 M
Income restructuring and M&A10 M
Income taxes966975.04 M4 M896622.0-106143.0-587642.0-2 M510816.03 M
Interest income-48549.0121385.032680.0111377.0193537.0388801.0132185.034806.0553104.0
InterestExpenseNonOperating10 M
MarketingExpense-65369.0-66722.0-136170.0-118975.0-123451.0155983.06959.095933.0
MiscOtherSpecialCharges2719.052.0-2048.0395912.0139213.018605.0
Net income from total operations2 M8 M7 M499764.06 M10 M1 M9 M13 M
NetIncomeCommonStockholders2 M8 M7 M499764.06 M10 M1 M9 M13 M
NetIncomeContinuousOperations2 M8 M7 M499764.06 M10 M1 M9 M13 M
NetNonOperatingInterestIncomeExpense-48549.0121385.032680.0111377.0193537.0388801.0132185.034806.0553104.0
NonRecurringOperationExpense146000.0
Normalized income18 M
Operating income3 M12 M11 M1 M6 M9 M-756091.010 M16 M
Operating income before depreciation (EBITDA)3 M12 M12 M3 M7 M10 M721946.011 M17 M
OperatingExpense-9 M-14 M-15 M-16 M-17 M21 M24 M22 M-26 M
Other income net-37412.0-89389.0-60997.06761.029308.08 M8 M-18605.0-8025.0
Other special charges9 M
OtherGandA5 M8 M9 M9 M9 M10 M12 M10 M11 M
OtherImpairmentOfCapitalAssets9 M8 M
OtherOperatingExpenses409594.0409594.0467572.0-534468.0
RentAndLandingFees5 M8 M9 M9 M9 M11 M
Research & development expense1 M2 M1 M2 M2 M1 M2 M2 M2 M
ResearchExpense1 M2 M1 M2 M2 M1 M2 M2 M2 M
RestructringAndMnAIncome10 M
Revenue per share-38499.0-36006.0-18017.0-82399.0-89333.089963.092945.0101735.0-101122.0
SalariesAndWages-724063.0-1 M-2 M-2 M-2 M8 M1 M-1 M
Selling Gen & administrative expense8 M12 M14 M15 M16 M20 M22 M20 M23 M
SellingAndMarketingExpense3 M5 M5 M6 M7 M9 M10 M11 M13 M
SellingExpense3 M5 M5 M6 M7 M13 M
Special income/charges55433.0-9 M-10 M
Total Income available for interest expense (EBIT)3 M12 M11 M1 M6 M9 M-616878.010 M16 M
Total common shares outstanding11 M11 M11 M11 M11 M12 M12 M13 M13 M
Total net income2 M8 M7 M499764.06 M10 M1 M9 M13 M
Total ordinary shares13 M13 M13 M13 M13 M13 M13 M13 M13 M
Total revenues16 M32 M32 M23 M30 M39 M32 M42 M53 M
TotalExpenses-13 M-20 M-22 M-22 M-24 M30 M32 M32 M-38 M
TotalRevenue16 M32 M32 M23 M30 M39 M32 M42 M53 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University